ICAM1 and chronic kidney disease: While, TNF signaling pathway, IL-17 signaling pathway, and NFκB signaling pathway were significantly enriched in our KEGG analysis of common DEGs, indicating the upregulation of ICAM1 in CKD and UC might be induced by TNFα- and IL-17-mediated NFκB activation in vivo.